Marketing-authorisation holder · United States
Xgen Pharms
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMPHOTERICIN B50mg/vial · Injectable | Amphotericin b | United States | Marketed | 1987 |
| CYCLOPHOSPHAMIDE100mg/vial | 1gm/vial | 200mg/vial | 2gm/vial | 500mg/vial · Injectable | Cyclophosphamide | United States | Marketed | 1986 |
| IBUPROFEN LYSINE20mg base/2ml (eq 10mg base/ml) · Injectable | Ibuprofen | United States | Marketed | 2016 |
| LEVETIRACETAM500mg/5ml (100mg/ml) · Injectable | Levetiracetam | United States | Marketed | 2010 |
| LIOTHYRONINE SODIUM0.01mg base/ml · Injectable | Liothyronine sodium | United States | Marketed | 2005 |
| NELARABINE250mg/50ml (5mg/ml) | 375mg/75ml (5mg/ml) · Injectable | Nelarabine | United States | Marketed | 2021 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States |